Lapatinib-plus-Pegylated Liposomal Doxorubicin in Advanced HER2-positive Breast Cancer Following Trastuzumab. A Phase II Trial

Category Primary study
JournalANTICANCER RESEARCH
Year 2015
This article has no abstract
Epistemonikos ID: eb96bb4bdc9a397f0a53ac03167258af726439a8
First added on: Nov 19, 2025